WILLIAM  WONG  to  Neoplasm Recurrence, Local
                            
                            
                                This is a "connection" page, showing publications  WILLIAM  WONG  has written about  Neoplasm Recurrence, Local.
                            
                            
                            
                                
                                    
                                            
    
        
        
        
            Connection Strength
            
                
            
            0.548
         
        
        
     
 
    
        
        - 
            Salvage radiotherapy for palpable, locally recurrent prostate cancer after radical prostatectomy. Int J Radiat Oncol Biol Phys. 2004 Apr 01; 58(5):1530-5.
            
            
                Score: 0.135
             
- 
            Cost-Effectiveness of Nivolumab in Recurrent Metastatic Head and Neck Squamous Cell Carcinoma. Oncologist. 2018 02; 23(2):225-233.
            
            
                Score: 0.086
             
- 
            Trends in mastectomy and reconstruction for breast cancer; a twelve year experience from a tertiary care center. Am J Surg. 2016 Dec; 212(6):1201-1210.
            
            
                Score: 0.080
             
- 
            Regional recurrence in the era of sentinel lymph node biopsy. Am J Surg. 2015 Dec; 210(6):1155-60; discussion 1160-1.
            
            
                Score: 0.075
             
- 
            Angiosarcoma of the scalp and face: the Mayo Clinic experience. JAMA Otolaryngol Head Neck Surg. 2015 Apr; 141(4):335-40.
            
            
                Score: 0.072
             
- 
            Outcomes in a multi-institutional cohort of patients treated with intraoperative radiation therapy for advanced or recurrent renal cell carcinoma. Int J Radiat Oncol Biol Phys. 2014 Mar 01; 88(3):618-23.
            
            
                Score: 0.067
             
- 
            Engagement with the HCV care cascade among high-risk groups: A population-based study. Hepatol Commun. 2023 09 01; 7(9).
            
            
                Score: 0.032